- Home
- FMS vs TOL Comparison
FMS vs TOL Comparison
Compare FMS & TOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMS
- TOL
- Stock Information
- Founded
- FMS 1996
- TOL 1967
- Country
- FMS Germany
- TOL United States
- Employees
- FMS N/A
- TOL 4900
- Industry
- FMS Misc Health and Biotechnology Services
- TOL Homebuilding
- Sector
- FMS Health Care
- TOL Consumer Discretionary
- Exchange
- FMS Nasdaq
- TOL Nasdaq
- Market Cap
- FMS 13.4B
- TOL 13.6B
- IPO Year
- FMS 1996
- TOL N/A
- Fundamental
- Price
- FMS $24.64
- TOL $135.10
- Analyst Decision
- FMS Hold
- TOL Buy
- Analyst Count
- FMS 1
- TOL 15
- Target Price
- FMS $25.00
- TOL $153.67
- AVG Volume (30 Days)
- FMS 213.3K
- TOL 1.2M
- Earning Date
- FMS 02-25-2025
- TOL 02-18-2025
- Dividend Yield
- FMS 2.58%
- TOL 0.68%
- EPS Growth
- FMS 46.47
- TOL 21.44
- EPS
- FMS 2.50
- TOL 15.01
- Revenue
- FMS $21,457,738,113.00
- TOL $10,846,740,000.00
- Revenue This Year
- FMS N/A
- TOL $2.34
- Revenue Next Year
- FMS $3.88
- TOL $7.53
- P/E Ratio
- FMS $19.37
- TOL $9.00
- Revenue Growth
- FMS N/A
- TOL 8.52
- 52 Week Low
- FMS $17.93
- TOL $97.38
- 52 Week High
- FMS $24.67
- TOL $169.52
- Technical
- Relative Strength Index (RSI)
- FMS 72.34
- TOL 52.54
- Support Level
- FMS $22.90
- TOL $134.38
- Resistance Level
- FMS $23.27
- TOL $137.17
- Average True Range (ATR)
- FMS 0.29
- TOL 3.10
- MACD
- FMS 0.18
- TOL 1.92
- Stochastic Oscillator
- FMS 98.66
- TOL 77.36
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.
About TOL Toll Brothers Inc.
Toll Brothers is the leading luxury homebuilder in the United States with an average sale price well above public competitors'. The company operates in over 60 markets across 24 states and caters to move-up, active-adult, and second-homebuyers. Traditional homebuilding operations represent most of company's revenue. Toll Brothers also builds luxury for-sale and for-rent properties in urban centers across the US It has its headquarters in Horsham, Pennsylvania.